Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Tree

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2025
Towards rapid and efficient simulation-free radiotherapy: MR guided adaptive prostate radiotherapy on the MR-Linac using diagnostic MRI reference planningJoan Chick, Francis Casey, Sian Cooper, et al.
European Urology Oncology|December 22, 2025
Magnetic Resonance Imaging-guided Focal Boost to Intraprostatic Lesions Using External Beam Radiotherapy for Localized Prostate Cancer: A Systematic Review and Meta-analysisDarren M C Poon, Jing Yuan, Bin Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2025
Predictors of Long-Term Disease-Free Survival With Stereotactic Body Radiation Therapy for Oligometastatic Prostate CancerBinnaz Yasar, Ewan Chapman, Helen Taylor, et al.
BMJ Oncology|April 3, 2025
Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluationJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
CA: a Cancer Journal for Clinicians|June 27, 2025
The contemporary management of prostate cancerDeep Chakrabarti, Peter Albertsen, Aidan Adkins, et al.
Clinical and Translational Radiation Oncology|September 30, 2020
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)Isabel Syndikus, Clare Cruickshank, John Staffurth, et al.
Clinical and Translational Radiation Oncology|June 14, 2024
Weekly ultra-hypofractionated radiotherapy in localised prostate cancerNora Sundahl, Douglas Brand, Chris Parker, et al.
Cancer Medicine|November 11, 2024
Is Centralisation of Cancer Services Associated With Under-Treatment of Patients With High-Risk Prostate Cancer?-A National Population-Based StudyLu Han, Emily Mayne, Joanna Dodkins, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2025
Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategiesJennifer Le Guevelou, Thomas Zilli, Federica Ferrario, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2025
Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in EnglandJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2025
Towards rapid and efficient simulation-free radiotherapy: MR guided adaptive prostate radiotherapy on the MR-Linac using diagnostic MRI reference planningJoan Chick, Francis Casey, Sian Cooper, et al.
European Urology Oncology|December 22, 2025
Magnetic Resonance Imaging-guided Focal Boost to Intraprostatic Lesions Using External Beam Radiotherapy for Localized Prostate Cancer: A Systematic Review and Meta-analysisDarren M C Poon, Jing Yuan, Bin Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2025
Predictors of Long-Term Disease-Free Survival With Stereotactic Body Radiation Therapy for Oligometastatic Prostate CancerBinnaz Yasar, Ewan Chapman, Helen Taylor, et al.
BMJ Oncology|April 3, 2025
Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluationJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
CA: a Cancer Journal for Clinicians|June 27, 2025
The contemporary management of prostate cancerDeep Chakrabarti, Peter Albertsen, Aidan Adkins, et al.
Clinical and Translational Radiation Oncology|September 30, 2020
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)Isabel Syndikus, Clare Cruickshank, John Staffurth, et al.
Clinical and Translational Radiation Oncology|June 14, 2024
Weekly ultra-hypofractionated radiotherapy in localised prostate cancerNora Sundahl, Douglas Brand, Chris Parker, et al.
Cancer Medicine|November 11, 2024
Is Centralisation of Cancer Services Associated With Under-Treatment of Patients With High-Risk Prostate Cancer?-A National Population-Based StudyLu Han, Emily Mayne, Joanna Dodkins, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2025
Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategiesJennifer Le Guevelou, Thomas Zilli, Federica Ferrario, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2025
Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in EnglandJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
Pageof 7